Free tool
Stocks listed on Nasdaq CM
We cover 34 companies listed on Nasdaq CM. The median market value in the group is $61.14M. Across the group, the median move over the past trading day is +0.41%. 85% of the 34 with a 200-day average trade above it. Price change over the past year runs from −40.8% to +609.5% across the middle 80 percent of the group, with a median of +44.9%.
Other lists in this group
Table
34 of 1,344 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| PLSE | Pulse Biosciences, Inc. | $48.10 | +35.61% | +259.22% | +203.47% |
| BLFS | BioLife Solutions, Inc. | $37.00 | +15.70% | +54.88% | +45.50% |
| FBRX | Forte Biosciences, Inc. | $76.99 | +0.44% | +226.09% | +589.87% |
| IMMX | Immix Biopharma, Inc. | $14.07 | +66.71% | +159.12% | +617.86% |
| ACHV | Achieve Life Sciences, Inc. | $8.27 | +33.82% | +66.40% | +177.52% |
| MCTA | Charming Medical Limited | $29.36 | 0.00% | 0.00% | +319.36% |
| RCEL | AVITA Medical, Inc. | $10.59 | +129.72% | +205.19% | +133.77% |
| SMTI | Sanara MedTech Inc. | $34.65 | +30.07% | +50.00% | +2.09% |
| ACB | Aurora Cannabis Inc. | $4.00 | +47.06% | −7.83% | −24.95% |
| CRDL | Cardiol Therapeutics Inc. | $2.14 | +78.33% | +115.29% | +91.07% |
| NGEN | NervGen Pharma Corp. | $2.21 | +37.27% | −62.41% | −8.30% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.30 | +24.38% | +43.58% | +7.93% |
| ORMP | Oramed Pharmaceuticals Inc. | $5.34 | +28.06% | +96.84% | +159.19% |
| SPRB | Spruce Biosciences, Inc. | $61.48 | +47.79% | −32.22% | +721.93% |
| EMPG | Empro Group Inc | $17.36 | 0.00% | 0.00% | +76.60% |
| DWTX | Dogwood Therapeutics, Inc. | $2.66 | +71.61% | −37.26% | −42.80% |
| INMB | INmune Bio Inc. | $2.45 | +42.98% | +58.77% | +19.56% |
| PRPO | Precipio, Inc. | $30.41 | +34.12% | +27.64% | +99.25% |
| HOWL | Werewolf Therapeutics, Inc. | $0.99 | +120.22% | +53.30% | −25.65% |
| HBIO | Harvard Bioscience, Inc. | $7.65 | +29.22% | +17.69% | +44.34% |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% |
| VYNE | VYNE Therapeutics Inc | $28.56 | +3080.40% | +4824.14% | +8660.74% |
| LEXX | Lexaria Bioscience Corp. | $11.04 | +36.30% | +1588.07% | +1146.05% |
| BCDA | BioCardia, Inc. | $1.19 | +52.56% | −6.30% | −38.66% |
| CMMB | Chemomab Therapeutics Ltd. | $2.59 | +81.12% | +44.69% | −25.57% |
| APRE | Aprea Therapeutics, Inc. | $0.98 | +59.61% | +14.89% | −38.75% |
| LUCY | Lucyd, Inc | $1.13 | +52.50% | −0.88% | −42.05% |
| FBLG | FibroBiologics, Inc. | $1.41 | +116.92% | −70.62% | −88.25% |
| XBIO | Xenetic Biosciences, Inc. | $3.86 | +54.40% | +79.53% | +35.92% |
| SKYE | Skye Bioscience, Inc. | $2.02 | +228.46% | +130.07% | −41.62% |
| CURX | Curanex Pharmaceuticals Inc | $4.60 | +2223.23% | +1150.00% | −1.29% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.33 | +710.86% | +426.12% | +211.51% |
| BIAF | bioAffinity Technologies, Inc. | $5.09 | +710.51% | +317.21% | −31.59% |
| SCNI | Scinai Immunotherapeutics Ltd. | $2.87 | +987.12% | +293.15% | +93.92% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.